Ignite Creation Date:
2025-12-24 @ 10:30 PM
Ignite Modification Date:
2026-02-11 @ 3:19 PM
Study NCT ID:
NCT00505635
Status:
TERMINATED
Last Update Posted:
2020-09-24
First Post:
2007-07-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Biochemotherapy With Temozolomide for Metastatic Melanoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DM03-0218
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None